美国代写论文 医药学论文代写
Poddar & Jain (2011) has explained that due to the down turn to the recession of global economy, the business world facing new challenges and opportunities as well and to work effectively in this global world they need to work jointly. They further explained that due to this jumble in global market the importance of merger and acquisition has become more clear and substantial and companies have started to use this process for restructuring their businesses in order to work effectively to meet the challenges and opportunities of global market. And on the other hand when we take in to account the pharmaceutical industry the imbalanced situation in research have also disturbed the market. “As an alternative, in pharmaceutical industry firms build strategies of merger and acquisition when faced obstacles in development of drugs and in patent process in order to strengthen their long term financial investments. Success of acquisitions is strongly related to the market behaviour, where demand and R&D fluctuating abnormally and investors expect exceptional returns in such situations” (Vass & Economopoulos, 2012). Rapid growth in R&D (Research and Development) in pharmaceutical industry has brought opportunities and threats among competitors. According to the report of (pharmacist.com, 2009) on “R&D in Pharmaceutical Industry” that pharmacists in United States spend 29% time of their job at work in research and development activities like improvement of existing products and development of new drugs.
oddar和耆那教（2011）解释说，由于下向全球经济的衰退，商业世界面临着新的挑战和机遇以及有效地工作在这个全球化的世界他们需要共同努力。他们进一步解释说，由于这种混杂在全球并购市场的重要性变得更加清晰和实质性的公司已经开始使用这一过程重组他们的企业为了有效地满足全球市场的机遇和挑战。另一方面，当我们在研究医药行业的不均衡的情况下，帐户也扰乱了市场。“作为一种替代，制药公司建造的并购战略时所面临的发展障碍的药物和专利的过程中为了加强他们的长期金融投资。成功的并购是市场行为密切相关，在需求和研发的异常波动，投资者期待特别的回报，在这种情况下，“（增值业务和科诺莫普洛斯，2012）。在研发快速增长（研究与发展）在医药行业带来了机遇和威胁的竞争对手。据报道（pharmacist.com，2009）在“研发在制药行业的“美国药剂师度过他们的工作29%的时间在研究与发展活动的像现有的产品和开发新药的改进工作。
